Harrow (HROW) Cash & Current Investments (2010 - 2026)

Harrow's (HROW) quarterly Cash & Current Investments came in at $94.6 million in Q1 2026, up 41.84% year-on-year from $66.7 million in Q1 2025, and up 29.78% quarter-over-quarter from $72.9 million in Q4 2025.

Harrow (HROW) Cash & Current Investments (2010 - 2026) Analysis & Trends

Harrow's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $94.6 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 41.84% year-over-year to $94.6 million in Q1 2026; TTM through Mar 2026 was $94.6 million, a 41.84% increase from a year earlier, with the FY2025 full-year figure at $72.9 million, up 54.35% from the prior year.
  • Cash & Current Investments grew to $94.6 million in Q1 2026 per HROW's latest filing, from $72.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $101.9 million in Q4 2022 and bottomed at $26.9 million in Q1 2023.
  • The 5-year median for Cash & Current Investments is $71.0 million (2024), against an average of $64.4 million.
  • Across the five-year window, Cash & Current Investments soared 677.83% in 2022 and slumped 46.87% in 2023, its largest moves.
  • Year by year, Cash & Current Investments stood at $101.9 million in 2022, then decreased by 18.74% to $82.8 million in 2023, then tumbled by 42.91% to $47.2 million in 2024, then surged by 54.35% to $72.9 million in 2025, then gained by 29.78% to $94.6 million in 2026.
  • Per Business Quant, the three latest HROW Cash & Current Investments figures stand at $94.6 million (Q1 2026), $72.9 million (Q4 2025), and $74.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.81 Bn 32.07 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.51 Bn 23.45 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.19 Bn 21.04 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.72 Bn 16.40 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.56 Bn 12.13 Bn 785.00 Mn 428.00 Mn
10 Harrow 1.39 Bn 1.30 Bn 27.05 Mn 94.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 94.64 Mn
Dec 31, 2025 72.93 Mn
Sep 30, 2025 74.29 Mn
Jun 30, 2025 52.96 Mn
Mar 31, 2025 66.73 Mn
Dec 31, 2024 47.25 Mn
Sep 30, 2024 72.60 Mn
Jun 30, 2024 70.97 Mn
Mar 31, 2024 75.97 Mn
Dec 31, 2023 82.77 Mn
Sep 30, 2023 73.88 Mn
Jun 30, 2023 29.67 Mn
Mar 31, 2023 26.88 Mn
Dec 31, 2022 101.86 Mn
Sep 30, 2022 49.12 Mn
Jun 30, 2022 51.63 Mn
Mar 31, 2022 50.59 Mn
Dec 31, 2021 50.67 Mn
Sep 30, 2021 67.85 Mn
Jun 30, 2021 85.06 Mn